ISRCTN90063632已完成不适用

Research on the comprehensive therapy for impaired glucose tolerance (IGT) by traditional Chinese medicine

Ministry of Science and Technology of the People's Republic of China (China)0 个研究点目标入组 2,000 人开始时间: 2008年7月10日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Both males and females
•2. 25 =< age <=70
•3. Intravenous plasma glucose: Fasting plasma glucose (FPG) <7.0 mmol/L and 2-hour plasma glucose (2hPG) of oral glucose tolerance test (OGTT) <11.1 mmol/L, >=7.8 mmol/L
•4. Deficiency of both qi and yin syndromes accompanied by heat
•5. Taking no medicine for treatment of IGT
•6. 18.5 kg/m2 < body mass index (BMI) <30 kg/m2
•7. Voluntariness, and signed letter of consent
•8. Those who do not take part in any other trails within 3 months

•1. Acute cardiovascular disease and myocardial infarction within 6 months
•2. Proliferative retinopathy that needs to be treated by laser
•3. Not compliant
•4. Mental disease
•5. Pregnant or lactating women; women without contraception
•6. Allergic to any traditional chinese medicine
•7. Co-morbid with other endocrine disease or serious protopathy
•8. Systolic blood pressure (SBP) >= 160 mmHg, diastolic blood pressure (DBP) >= 100 mmHg and secondary hypertension
•9. Cholesterol (CHO) >= 6.22 mmol/L(240 mg/dl) or low density lipoprotein (LDL) >= 4.14 mmol/L (160 mg/dl)
•10. Patients who are treated by other hypoglycemic drug

发起方

Ministry of Science and Technology of the People's Republic of China (China)